A patient with acute kidney injury (AKI) presents with hyperkalemia and symptoms of fluid overload. Which intervention should the nurse prioritize to address the patient's critical needs?

A) Administer intravenous furosemide to promote diuresis.

B) Provide continuous cardiac monitoring to detect arrhythmias.

D) Prepare the patient for hemodialysis to remove excess potassium.

A patient with acute kidney injury (AKI) and hyperkalemia is showing peaked T-waves on the ECG. The healthcare team has administered intravenous calcium gluconate and insulin with glucose. Which additional intervention should the nurse anticipate to help reduce the patient's serum potassium level?

A) Administer sodium polystyrene sulfonate orally

B) Increase the infusion rate of intravenous fluids

C) Prepare the patient for hemodialysis

D) Administer a potassium-sparing diuretic

A patient with acute kidney injury (AKI) is receiving loop diuretics and has shown some improvement in peripheral edema and shortness of breath. However, laboratory results indicate a serum potassium level of 5.8 mEq/L, a serum creatinine level of 3.3 mg/dL, and a serum sodium level of 130 mEq/L. What is the priority nursing intervention at this time?

C) Monitor fluid balance closely and prepare for potential dialysis.

A) Administer a potassium-binding resin to lower serum potassium levels.

B) Restrict sodium intake to address hyponatremia.

C) Monitor fluid balance closely and prepare for potential dialysis.

D) Increase the frequency of diuretic administration to enhance fluid removal.

A patient with acute kidney injury (AKI) is being treated with loop diuretics and insulin with glucose to manage fluid overload and hyperkalemia. Despite some clinical improvements, the patient's serum potassium remains elevated, and serum sodium has dropped to 130 mEq/L. What is the most appropriate nursing intervention to prioritize at this time?

C) Monitor for signs of electrolyte imbalance and coordinate with nephrology for potential renal replacement therapy.

A) Increase the dose of loop diuretics to enhance fluid removal.

B) Administer a hypertonic saline solution to correct hyponatremia.

C) Monitor for signs of electrolyte imbalance and coordinate with nephrology for potential renal replacement therapy.

D) Withhold insulin and glucose administration to prevent further sodium drop.

A patient with acute kidney injury presents with a sudden onset of confusion, disorientation, and asterixis. The electrolyte panel reveals serum sodium of 128 mEq/L and serum potassium of 5.5 mEq/L. Which of the following interventions should the nurse prioritize to address the patient's altered mental status?

A) Administer intravenous hypertonic saline cautiously.

B) Increase the rate of intravenous normal saline.

C) Prepare the patient for emergent dialysis.

D) Administer oral potassium supplements.

A patient with acute kidney injury and worsening hyponatremia presents with confusion and agitation. The healthcare team is considering the use of hypertonic saline to address the low sodium levels. Which nursing intervention is most important to implement during the administration of hypertonic saline?

B) Assess the patient's neurological status frequently.

A) Monitor the patient's blood glucose levels hourly.

B) Assess the patient's neurological status frequently.

C) Encourage the patient to increase oral fluid intake.

D) Place the patient in a Trendelenburg position to improve cerebral perfusion.

While monitoring a patient with suspected hepatic encephalopathy and renal impairment, the nurse observes the development of tremors and dysarthria. Which of the following actions should the nurse prioritize to manage these symptoms effectively?

C) Administer lactulose as prescribed to reduce ammonia levels and monitor stool frequency.

A) Increase the infusion rate of hypertonic saline to correct sodium levels more rapidly.

B) Collaborate with the healthcare team to evaluate and adjust the patient's medication regimen, focusing on potential hepatotoxic drugs.

C) Administer lactulose as prescribed to reduce ammonia levels and monitor stool frequency.

D) Restrict fluid intake to prevent potential fluid overload and worsening renal function.

A patient with suspected hepatic encephalopathy is being monitored after receiving hypertonic saline for hyponatremia. The patient exhibits confusion, tremors, asterixis, and mild dysarthria. What is the priority nursing action at this time?

A) Administer lactulose as prescribed to reduce ammonia levels

B) Increase the rate of hypertonic saline infusion to correct sodium levels faster

C) Prepare the patient for an immediate CT scan of the head

D) Monitor liver function test results and report any significant changes to the provider

A patient with suspected hepatic encephalopathy has elevated ammonia levels. The healthcare team has initiated lactulose therapy. Which nursing intervention is most important to ensure the effectiveness of this treatment?

A) Administer lactulose as ordered and monitor for diarrhea.

B) Restrict the patient's protein intake to prevent further ammonia production.

C) Encourage increased fluid intake to promote renal excretion of toxins.

D) Monitor vital signs closely for signs of hypotension.

A patient with elevated liver enzymes, increased bilirubin, and high ammonia levels is diagnosed with hepatic encephalopathy. The healthcare team plans to initiate lactulose therapy. Which nursing intervention is most important to monitor in this patient's plan of care to ensure the effectiveness of lactulose therapy?

D) Evaluate the patient's bowel movement frequency and consistency

A) Monitor the patient's blood pressure every 4 hours

B) Assess the patient's level of consciousness regularly

C) Measure the patient's urinary output every shift

D) Evaluate the patient's bowel movement frequency and consistency

acute kidney injury - Nursing Case Study

Pathophysiology

• Primary mechanism: Reduced blood flow to the kidneys (prerenal azotemia) leads to decreased glomerular filtration rate (GFR), impairing the kidneys' ability to filter waste, often due to hypotension or volume depletion.

• Secondary mechanism: Direct damage to kidney tissues (intrinsic injury), commonly from acute tubular necrosis (ATN), results from ischemia or nephrotoxins, causing impaired tubular function and cellular injury.

• Key complication: Fluid overload and electrolyte imbalances, such as hyperkalemia, can develop due to impaired excretion, leading to potentially life-threatening cardiac and systemic complications.

Patient Profile

Demographics:

65-year-old male, retired factory worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes Mellitus, Chronic Obstructive Pulmonary Disease (COPD)

• Current medications: Lisinopril, Metformin, Albuterol Inhaler

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Decreased urine output and fatigue

• Key symptoms: Swelling in legs, shortness of breath, confusion, nausea

• Vital signs: Blood pressure 160/95 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, temperature 37.8°C, oxygen saturation 91% on room air

Section 1

As the healthcare team conducts an initial assessment of the patient, several critical findings emerge that warrant immediate attention. The patient's rapid onset of confusion and pronounced peripheral edema, particularly in the lower extremities, suggest worsening fluid overload. Auscultation reveals bilateral crackles in the lung bases, indicating pulmonary congestion, likely exacerbating the patient's shortness of breath. Laboratory results show elevated serum creatinine at 3.5 mg/dL and blood urea nitrogen (BUN) at 55 mg/dL, confirming the diagnosis of acute kidney injury (AKI) with a prerenal component due to decreased perfusion. A urinalysis reveals muddy brown casts, suggesting acute tubular necrosis as a contributing intrinsic factor.

Electrolyte imbalances present a crucial concern, with serum potassium levels elevated at 6.2 mEq/L, putting the patient at risk for potentially life-threatening cardiac arrhythmias. The electrocardiogram (ECG) displays peaked T-waves, a hallmark sign of hyperkalemia. These findings necessitate immediate intervention to stabilize the patient and prevent further complications. The healthcare team initiates treatment with intravenous calcium gluconate to stabilize cardiac membranes and administers insulin with glucose to facilitate intracellular shifting of potassium. Additionally, a loop diuretic is considered to promote renal excretion of excess fluid and potassium, provided the patient's hemodynamic stability allows.

The patient's clinical picture underscores the importance of careful monitoring and timely interventions. Continuous cardiac monitoring, frequent reassessment of vital signs, and serial laboratory evaluations are essential to track the patient's response to treatment. The complexity of managing AKI in the context of multiple comorbidities, such as hypertension and diabetes, requires a multidisciplinary approach to optimize fluid balance, maintain electrolyte homeostasis, and ultimately improve renal function. As the team addresses these urgent issues, they remain vigilant for any signs of further deterioration or new complications, setting the stage for ongoing evaluation and management in the patient's journey toward recovery.

Section 2

The healthcare team closely monitors the patient's response to the initial interventions aimed at managing the acute kidney injury and associated complications. Within a few hours, the patient demonstrates some positive responses; the peripheral edema shows mild reduction, and the patient's shortness of breath slightly improves, with auscultation revealing a slight decrease in crackles at the lung bases. These changes suggest that the loop diuretic is beginning to facilitate fluid removal, though careful monitoring of the patient's hemodynamic status remains crucial to avoid hypovolemia.

Despite these improvements, the laboratory results obtained shortly after intervention underscore the complexity of the patient's condition. The serum potassium level, although reduced, remains elevated at 5.8 mEq/L, necessitating continued vigilance and possibly repeated doses of insulin with glucose to further facilitate intracellular potassium shifting. The patient's serum creatinine remains high at 3.3 mg/dL, indicating that renal function has not yet significantly improved. The electrolyte panel also reveals a concerning drop in serum sodium to 130 mEq/L, highlighting the risk of hyponatremia, which could exacerbate the patient's confusion and alter mental status.

As the healthcare team evaluates these new diagnostic results, they consider additional interventions and adjustments to the treatment plan. The patient's blood pressure, which has been stable, must be continuously monitored to ensure adequate renal perfusion. Collaborating with the nephrology and cardiology teams, the goal is to refine fluid management strategies, perhaps by adjusting diuretic dosing or employing renal replacement therapy if necessary. This ongoing assessment and adaptive response are vital in navigating the patient's journey toward recovery, with an unwavering focus on preventing new complications while addressing existing ones.

Section 3

As the healthcare team continues to monitor the patient, a new complication arises that requires immediate attention. Overnight, the patient experiences a sudden onset of confusion and displays signs of agitation, which prompts a thorough neurological assessment. The nurse notes that the patient is disoriented to time and place and exhibits asterixis, a telltale sign of metabolic disturbances. Vital signs reveal a slight decrease in blood pressure to 105/68 mmHg, and heart rate is mildly elevated at 98 beats per minute. Respiratory rate remains steady at 20 breaths per minute, but oxygen saturation has dipped to 92% on room air. These findings raise concern for potential worsening of electrolyte imbalances, particularly hyponatremia, which could be contributing to the patient's altered mental status.

In response, the team orders an urgent repeat of the electrolyte panel, which confirms a further decline in serum sodium to 128 mEq/L, signaling a progression of hyponatremia. In light of this, the healthcare team decides to initiate a cautious sodium correction strategy to prevent rapid shifts that could lead to osmotic demyelination syndrome. Meanwhile, the patient's serum potassium has decreased slightly to 5.5 mEq/L, suggesting a partial response to the insulin and glucose treatment. However, the creatinine level remains elevated at 3.2 mg/dL, indicating ongoing renal impairment.

To address the evolving situation, the team collaborates to adjust the fluid management plan, balancing diuretic therapy with the need to correct sodium levels. The nephrology team suggests the potential use of hypertonic saline in a controlled setting, closely monitoring for any adverse effects. Concurrently, the cardiology team evaluates the patient's cardiac status to ensure that any fluid strategy does not exacerbate heart failure. This coordinated approach highlights the importance of integrating clinical reasoning and interdisciplinary collaboration to navigate the complexities of acute kidney injury and its complications, setting the stage for the next phase of the patient's recovery journey.

Section 4

As the care team implements the sodium correction strategy, the patient's condition undergoes further changes. After administering a carefully calculated dose of hypertonic saline, the team closely monitors the patient's neurological status and electrolytes. Over the next few hours, the patient's serum sodium level gradually increases to 130 mEq/L. Despite this improvement, the patient's confusion persists, and new signs of tremors are observed, raising concerns about potential worsening of neurological symptoms. Vital signs are checked frequently: blood pressure has stabilized at 110/70 mmHg, heart rate is 92 beats per minute, respiratory rate remains steady at 20 breaths per minute, but oxygen saturation has slightly improved to 94% on room air.

In response to these developments, the healthcare team conducts an urgent repeat of the neurological assessment, which reveals the persistence of asterixis and now the presence of mild dysarthria. Given these findings, the team suspects that the patient may be developing hepatic encephalopathy, a condition often associated with liver dysfunction and metabolic derangements. Further lab work is ordered, including liver function tests, to explore this possibility. Meanwhile, the nephrology team maintains a delicate balance in fluid management to ensure that neither the sodium correction nor the diuretic therapy exacerbates the patient's condition.

The interdisciplinary team continues to collaborate, with the hepatology team joining the efforts to evaluate the potential hepatic involvement. The coordination of care emphasizes the importance of addressing the interplay between the patient's renal impairment and possible liver dysfunction. The team's next steps focus on optimizing the treatment plan to stabilize the patient's neurological status, while simultaneously preventing additional complications, setting the stage for further diagnostic exploration and targeted therapeutic interventions.

Section 5

New Diagnostic Results:

As the healthcare team awaits the results of the liver function tests, they remain vigilant about monitoring the patient's condition. The team receives the lab results, which reveal elevated liver enzymes: AST at 85 U/L and ALT at 90 U/L, indicating potential liver stress. Additionally, the patient's bilirubin level has risen to 2.8 mg/dL, further suggesting possible hepatic dysfunction. Ammonia levels are significantly elevated at 85 µmol/L, supporting the suspicion of hepatic encephalopathy. The new findings prompt the interdisciplinary team to consider adjusting the patient's treatment plan to address these hepatic concerns.

Recognizing the importance of these results, the hepatology team recommends initiating lactulose therapy to help reduce the ammonia levels and alleviate neurological symptoms. The nephrology team, aware of the patient's renal status, advises careful monitoring of electrolyte balance and fluid status to prevent any further complications. The care team also discusses the possibility of introducing rifaximin to enhance the reduction of ammonia production in the gut, though this will be contingent on the patient's response to initial therapy.

These diagnostic findings underscore the complexity of the patient's condition, highlighting the critical interplay between renal and hepatic systems. The multidisciplinary team emphasizes the need for continued collaboration and close monitoring to optimize the patient's treatment and prevent further deterioration. The next steps involve reassessing the patient's neurological status and adjusting interventions based on the evolving clinical picture, paving the way for a more targeted and effective management strategy.